tiprankstipranks
AnaptysBio Inc (ANAB)
NASDAQ:ANAB

Compare AnaptysBio (ANAB) vs. Competitors

662 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
AnaptysBio
$65.54
$1.88B
-101.81
285.98%
9 Buy
1 Hold
0 Sell
Strong Buy
Meiragtx Holdings
$9.39
$764.78M
-5.60
79.20%
4 Buy
0 Hold
0 Sell
Strong Buy
Keros Therapeutics
$12.55
$247.46M
8.71
28.59%
5 Buy
3 Hold
0 Sell
Moderate Buy
Compass Therapeutics
$5.40
$972.47M
-12.74
239.62%
9 Buy
0 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$15.69
$1.37B
-13.39
412.75%
10 Buy
1 Hold
0 Sell
Strong Buy
Terns Pharmaceuticals
$52.66
$6.08B
-39.12
2468.78%
0 Buy
9 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ANAB
AnaptysBio
65.54
49.30
303.57%
MGTX
Meiragtx Holdings
9.39
4.32
85.21%
KROS
Keros Therapeutics
12.55
0.31
2.53%
CMPX
Compass Therapeutics
5.40
3.75
227.27%
OLMA
Olema Pharmaceuticals
15.69
12.28
360.12%
TERN
Terns Pharmaceuticals
52.66
50.52
2360.75%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts